evitria AG – We are a leading service provider
for recombinant antibody expression
in CHO cells.

  • 5 weeks from sequence to recombinant antibody
  • 1 – 2 weeks for reproduction
  • very low levels of endotoxin (<1 EU/mg)
evitria - leading service provider for recombinant antibody expression in CHO cells

Why our customers choose us

expertise through focus

1. Expertise through focus

Since our inception in 2010, we focus on one service only, recombinant antibody expression in CHO cells. We only do one thing, but we do it right.

Speed

2. Speed

All projects begin within 24 hours of your approval, often leading to record-setting completion times.

Reliability

3. Reliability

Our focus and singular offering allow us to deliver our promises with respect to turnaround time, material quantity, and exceptional quality.

0 >

Antibody production runs

0 < day

Lead time

0 > %

Projects completed on time

Other proteins
services other proteins
Recombinant antibodies
services recombinant antibodies
Afucosylated antibodies
Services afucosylated antibodies
Fc-silenced antibodies
Fc-silenced antibodies to remove effector functions
Other proteins
services other proteins
Recombinant antibodies
services recombinant antibodies
Afucosylated antibodies
Services afucosylated antibodies
Fc-silenced antibodies
Fc-silenced antibodies to remove effector functions

Recombinant antibodies

multiple species – including chimeric, bispecific, Fc-optimized and fusion antibodies as well as Fc fusion proteins

Afucosylated antibodies

afucosylated antibodies for increased ADCC activity

Fc-silenced antibodies

Fc-silenced antibodies to remove effector functions

Other proteins

any secreted protein – delivered for in-house purification

From sequence to antibody in 5 weeks

project start - how we work at evitria

Project start

0-1 business days

pilot study (from electronic sequence to quantified pilot supernatant)

Pilot study

(from electronic sequence to quantified pilot supernatant)

15-20 business days

larger-scale expression - how we work at evitria

Larger-scale expression

5-10 business days

purification - how we work at evitria

Purification

2-3 business days

final analytics - how we work at evitria

Final analytics

2-3 business days

shipment - how we work at evitria

Shipment

1-2 business days

How to order with evitria

You tell us what you need and when

Optional: We discuss your project and how we might be able to assist in a personal conversation

You receive our proposal within one working day

You review and approve our proposal

Your project begins within one working day

8 Pleasant cooperation
9.5 Efficient cooperation
8 Quality (purification)
9.5 Speed of processing
7.5 Value for money
6 Service portfolio scope

That's what
our customers say:

“I really like the speed, quality, and customer service from evitria.”

“evitria is so fast that we sometimes receive the antibody even before we can raise the PO”

“Without evitria's services, our company would not be where it is now. Thank you!”

8 Pleasant cooperation
9.5 Efficient cooperation
8 Quality (purification)
9.5 Speed of processing
7.5 Value for money
6 Service portfolio scope

evitria / market average

2020 customer satisfaction survey:
"How do you rate evitria
on a scale from 1 to 10 compared to the industry average (5)?"

Global Presence – Local Touch

evitria global presence - local address

evitria Headquarters

Zurich, Switzerland

Dr. Stefan Schmidt - CEO evitria AG

Contact: Stefan Schmidt, CEO

evitria Americas West

San Diego, USA

Contact: Lisa Meza

Mail: lm@evitria.com

evitria Americas East

Boston, USA

Contact: Richard Park

Mail: rp@evitria.com

evitria Europe

London, Great Britain

Contact: Desmond Schofield

Mail: ds@evitria.com

evitria Asia Pacific

Singapore

Recommended articles

February 29, 2024 duration: 9 min

An Introduction to Recombinant Antibodies: 7 Key Insights

From the application in medicine and science to recombinant antibody production and the advantages of recombinant Abs in contrast to traditional monoclonal antibodies, this article will teach you all you need to know about recombinant antibodies.

Desmond Schofield

Desmond Schofield

Director of Business Development at evitria
November 21, 2023 duration: 6 min

Afucosylated recombinant antibodies

Generally speaking, antibodies of any kind, including recombinant and afucosylated antibodies, are Y-shaped proteins produced by the human body. As they are able to identify and neutralize foreign objects – in other words viruses – they play a major contributing role in keeping our body and immune system healthy.

Desmond Schofield

Desmond Schofield

Director of Business Development at evitria
September 30, 2021 duration: 6 min

Antibody-Dependent Cellular Cytotoxicity (ADCC) – definition, mechanism & application

Antibody-dependent cellular cytotoxicity is a key process of the immune system’s arsenal to ward off cancerous cells and infections. We show you important definitions and the ADCC mechanism and key facts on ADCC antibodies in this post.

Desmond Schofield

Desmond Schofield

Director of Business Development at evitria
May 24, 2023 duration: 6 min

Transient antibody production simply explained

Transient antibody expression is a very popular choice for the production of different antibodies. In this article, we will take a look at the procedure of transient antibody production.

Richard Park

Richard Park

Global Head, Client Relations and Business Development at evitria
Get in Touch

    Subscribe to the evitria newsletter and stay up to date